Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients. [electronic resource]
Producer: 20150615Description: 663-9 p. digitalISSN:- 1476-5527
- Aged
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Benzimidazoles -- therapeutic use
- Biphenyl Compounds
- Blood Pressure -- drug effects
- Cardiovascular Diseases -- diagnosis
- Diabetes Mellitus, Type 2 -- diagnosis
- Enalapril -- therapeutic use
- Female
- Humans
- Hypertension -- diagnosis
- Incidence
- Male
- Middle Aged
- Primary Health Care
- Retrospective Studies
- Risk Factors
- Sweden -- epidemiology
- Tetrazoles -- therapeutic use
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.